Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.425 USD | +2.91% | -1.88% | -50.06% |
Apr. 22 | Chardan Initiates Prime Medicine With Buy Rating, Price Target is $17 | MT |
Apr. 22 | Chardan Initiates Prime Medicine at Buy With $17 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.06% | 510M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- PRME Stock
- News Prime Medicine, Inc.
- Prime Medicine Names Foghorn Therapeutics' CFO to be its New Finance Chief